Many insured cancer patients still experience serious money problems linked to their illness, new research affirms.
For example, nearly 3 out of 4 insured patients with colon cancer have major financial hardship in the year after their diagnosis, which affects their social functioning and quality of life, according to
Here's a social distancing strategy that really worked in the early days of the pandemic: New research shows that providing hotel rooms to homeless people at high risk for severe COVID-19 significantly lowered their chance of infection.
In early April 2020, the city of Chicago made 200 rooms at a hotel available to homeless people in shelters who were considered at high risk because they ...
Big "surprise" medical bills may still be a problem for Americans.
According to a new study, more than half of U.S. hospitals haven't complied with recent regulations requiring that they disclose their prices online for all services, to help prevent unexpected bills for patients.
About 55% of hospitals have yet to comply with the
President Joe Biden promised cheaper prescription drugs for all Americans on Monday as his social agenda legislation winds its way through Congress.
Biden tried to shift Americans' focus to pocketbook provisions overlooked in his $2 trillion legislation, which deals with everything from climate to family life and taxes. The legislation has passed the House and is pending before the Senate...
Nearly 13 million U.S. adults a year skip or delay filling needed prescriptions due to high price tags, new research shows.
This figure includes more than 2.3 million Medicare beneficiaries and 3.8 million privately insured working-age adults who didn't get needed medications each year in 2018 and 2019 because of cost, according to a nationally representative survey of U.S. households.
Vice President Kamala Harris announced Monday that the Biden administration will spend $1.5 billion to tackle a health care worker shortage in underserved communities.
The money from the COVID-19 recovery program, called the American Rescue Plan, and other sources will go to three federal programs that provide scholarships and loan repayments for health care students and workers if they a...
Neurologists must make sure Alzheimer's patients and their families understand that the controversial drug aducanumab does not restore mental function, the American Academy of Neurology (AAN) said in new position statement that includes ethical guidelines.
"Aducanumab is not a cure for Alzheimer's disease, yet since it has been approved by the [U.S. Food and Drug Administration], patients...
Lung cancer survival rates in the United States continue to rise, but certain racial groups are still hit hard by the disease, the American Lung Association reports.
Its fourth annual "State of Lung Cancer" report shows that the average five-year survival rate increased from 14.5% to nearly 24%, but it remains at 20% for people of color overall, and 18% for Black Americans.
A new and expensive Alzheimer's drug called Aduhelm is responsible for about half of the $21.60 increase in monthly premiums for Medicare's Part B outpatient program in 2022, Medicare officials report.
The new premium will be $170.10 a month, and the $21.60 boost is the biggest increase ever in dollar amount, but not in percentage terms. As recently as August, a smaller increase of $10 fr...
Health insurance has gotten slightly more expensive during the pandemic: A new survey shows that annual family premiums for employer-sponsored health insurance rose 4%, to an average of $22,221 this year.
Of that amount, employees paid an average of nearly $6,000 toward the cost of coverage, while employers paid the remainder of the premium.
A measure designed to lower prescription drug costs for seniors has been added to President Joe Biden's social safety net and climate change bill that Democratic leaders hope to bring to a House vote this week.
For the first time, the measure would enable the federal government to negotiate prices for medications covered by Medicare, The New York Times reported.
The joys of motherhood may be overshadowed in the United States since as many as 50% of new or expectant moms can't pay their bills, including health care bills, new research suggests.
"Financial hardship is highly prevalent among pregnant and postpartum women," said study co-author Dr. Michelle Moniz. She is an assistant professor of obstetrics and gynecology at the University of Michiga...
American cancer patients spent more than $21 billion on their care in 2019, a new report shows.
That $21.09 billion included out-of-pocket costs of $16.22 billion and patient time costs of $4.87 billion. Patient time costs are the value of the time patients spend traveling for, waiting for and receiving care.
"As the costs of cancer treatment continue to rise, greater attention to a...
Antibody infusions help keep high-risk COVID-19 patients out of the hospital, but getting the therapy can be a challenge. One U.S. health system has found a creative way to address the problem: home infusions administered by paramedics.
Researchers found that the tactic was feasible, delivering antibody infusions to 144 COVID-19 patients in their homes over three months earlier this year....
Affordable over-the-counter hearing aids could soon bring relief to millions of Americans suffering from hearing loss, under a landmark proposal announced Tuesday by the U.S. Food and Drug Administration.
The proposal would create a category of hearing aids that could be sold directly to consumers, without either a medical exam or a fitting by an audiologist.
Americans hospitalized with COVID-19 could now face thousands of dollars in out-of-pocket medical costs, according to a new report.
In 2020, most health insurance companies waived co-pays, deductibles and other cost-sharing for hospitalized COVID-19 patients, but many stopped doing that early this year, the University of Michigan researchers noted.
Just over a decade ago, the passage of the Affordable Care Act (ACA, or Obamacare) made many common cancer screenings free. But a pair of new studies caution that when those free tests turn up signs of trouble, important follow-up tests may be too pricey for some patients.
The bigger concern: Some patients may forgo these expensive tests, even when they may prove lifesaving.
When the COVID-19 public health emergency ends, a new crisis in insurance coverage in the United States may begin.
Fifteen million Americans who enrolled in Medicaid during the pandemic could lose their coverage when the emergency declaration ends, according to an analysis by the Urban Institute, a social policy think tank.
Its researchers said states can minimize disenrollment by k...
The cost of providing hospital care for unvaccinated Americans has reached $5.7 billion in just three months, CBS News reported.
Between June and August, about 287,000 people who were not vaccinated were hospitalized for COVID-19 in the United States, according to data from the Kaiser Family Foundation (KFF) and the Peterson Center on Healthcare, which collaborated to track healt...
While the cost of administering COVID-19 vaccines is nominal -- and free to consumers in the United States -- the cost of paying for hospitalizations for people who've contracted the virus is dramatically higher.
The average financial cost of hospitalization for a COVID-19 patient insured by Medicare - at $21,752 -- is about 145 times the reimbursement Medicare pays for vaccinating one pe...
Tax-free health savings accounts can make it easier for Americans to pay for future health expenses, but most older adults aren't using them.
A new poll by Michigan Medicine-University of Michigan found that while nearly 1 in 5 people weren't confident that they could afford their health costs, only about 12% of people had a flexible spending account (FSA). And just 45% of people who qual...
COVID-19 care is likely to get more expensive for Americans with the expiration of insurers' temporary waivers on costs associated with treating the illness.
Earlier in the pandemic, patients didn't have their normal co-payments or deductibles for emergency room visits or hospital stays for COVID-19, and most tests were also free, The New York Times reported.
In a paradoxical finding, new research reveals that more Americans of color have access to health insurance now than they did 20 years ago, but their perceptions of their health status have not improved at all.
The study, published Aug. 17 in the Journal of the American Medical Association, paints a sobering picture.
In the bit of good news, researchers found that bet...
Anesthesia is a vital part of almost every surgery, but unexpected bills for the service can cause a lot of pain. Now, a new study finds that these costs fell in several states that introduced legislation targeting "surprise" billing.
"These price declines show that state surprise billing laws both directly lower out-of-network prices and indirectly lower in-network prices, providing evid...
The two HIV prevention drugs available in the United States are equally safe and effective, and the biggest difference between them is price, a new study contends.
However, a sizable minority of patients have switched from the older and cheaper "preexposure prophylaxis" (PrEP) formulation to the newer and much pricier one. In many cases that switch might not have been warranted, the resea...
Ernie Mundell and Robert Preidt HealthDay Reporters
As many Americans know, today's health insurance plans often come with high deductibles. Those out-of-pocket costs could cause harm: New research shows that 20% of people who have diabetes and high-deductible health plans regularly skip their medications.
Not keeping up with your diabetes medications comes with the potential risk of an emergency room visit or a hospitalization.
U.S. pharmacists will now be able to automatically substitute a cheaper biosimilar for a more expensive brand-name insulin, the U.S Food and Drug Administration announced Wednesday.
The agency's approval of an "interchangeable" biosimilar could save diabetics and health plans millions each year, the Associated Press reported. Until now, doctors have had to specifically prescribe ...
People of color are consistently less likely to see medical specialists than white patients are, a new U.S. study finds, highlighting yet another disparity in the nation's health care system.
Researchers found that compared with their white counterparts, Black Americans, Hispanic Americans and Asian Americans had significantly fewer visits to doctors of various specialties -- ranging from...
The controversial new Alzheimer's drug Aduhelm is creating something of a civil war in medicine, as health networks, hospitals, insurers and individual doctors weigh impending discussions with patients about whether they should take the medication.
Many doctors believe the U.S. Food and Drug Administration "moved the goalposts" to approve Aduhelm (aducanumab) in early June, and they aren'...
The coronavirus pandemic has left plenty of Americans saddled with medical bills they can't pay, a new survey reveals.
More than 50% of those who were infected with COVID-19 or who lost income due to the pandemic are now struggling with medical debt, according to researchers from The Commonwealth Fund, a nonprofit organization that advocates a high-performing health care system.
The Affordable Care Act (ACA) has eased financial struggles for younger adult cancer survivors, a new study finds.
University of Michigan researchers analyzed data from more than 20,000 participants in the National Health Interview Survey and found that cancer survivors ages 18 to 64 were less likely to delay treatments and had less difficulty paying for medications or dental care from 20...
TUESDAY, July 13, 2021 (Healthday News) -- Medicare launched a formal process on Monday that will determine whether the agency will cover Aduhelm, the newly approved Alzheimer's drug whose high price tag and unproven benefits have prompted widespread controversy.
Medicare's announcement came the same day that leaders of two House committees that are investigating Aduhelm's approval asked ...
THURSDAY, July 1, 2021 (Healthday News) -- The U.S. Food and Drug Administration's controversial approval of a new Alzheimer's drug, along with its high price, is now being investigated by two House committees.
"We have serious concerns about the steep price of Biogen's new Alzheimer's drug Aduhelm and the process that led to its approval despite questions about the drug's clinical benefi...